GC
BVS icon

Globeflex Capital’s Bioventus BVS Stock Holding History

Globeflex Capital’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.57M Buy
165,865
+42,813
+35% +$409K 0.2% 126
2026
Q1 		$1.12M Buy
123,052
+45,936
+60% +$385K 0.17% 140
2025
Q4 		$574K Hold
77,116
– – 0.09% 227
2025
Q3 		$516K Sell
77,116
-13,151
-15% -$91.3K 0.08% 246
2025
Q2 		$598K Hold
90,267
– – 0.05% 244
2025
Q1 		$826K Hold
90,267
– – 0.08% 198
2024
Q4 		$948K Hold
90,267
– – 0.08% 194
2024
Q3 		$1.08M Buy
+90,267
New +$780K 0.1% 175

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Globeflex Capital's BVS Position: Q2 2026 in Review

Globeflex Capital increased its Bioventus (BVS) stake by 35% in Q2 2026, buying an estimated $409K and bringing the position to 165,865 shares worth $1.57M. The position accounts for 0.2% of the portfolio, ranked #126.

Globeflex Capital first reported a position in BVS in Q3 2024 and has held it in 8 quarters since. 156 funds tracked by Wall St. Rank hold BVS as of Q2 2026.

  • Globeflex Capital held 165,865 shares of Bioventus worth $1.57M as of Q2 2026.
  • Globeflex Capital bought 42,813 Bioventus shares in Q2 2026, an estimated $409K.
  • Bioventus made up 0.2% of Globeflex Capital's portfolio in Q2 2026, its #126 holding.
  • Globeflex Capital first reported a position in Bioventus in Q3 2024 and has held it in 8 quarters since.
  • 156 funds tracked by Wall St. Rank held Bioventus as of Q2 2026.

Based on Globeflex Capital's 13F filing for Q2 2026, filed 12 Aug 2026.